Medical-Grade Chitosan Endotoxin Removal Without Polymer Degradation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing endotoxin-free chitosan are economically unviable and fail to maintain high molecular weight, leading to contamination issues in medical applications due to residual endotoxins, which are toxic and immunogenic, limiting the use of chitosan in implantable devices and biomedical applications.
Innovation Solution
A process involving suspending chitosan fibers in an aqueous alcohol solution, raising the pH with ammonia, heating at temperatures above 130°C for at least 20 minutes, cooling, sparging with an inert gas, rinsing with endotoxin-free liquid, and drying below 100°C to effectively remove endotoxins while preserving molecular weight and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional methods are used to remove endotoxins from chitosan, then endotoxin levels are reduced, but molecular weight is degraded and production cost increases
Solution Approach 1:
The patent changes the chemical parameters of the treatment solution by using a mild basic solution (pH 10-12) instead of harsh chemicals, and controls temperature parameters (heating to 60-100°C for 30-120 minutes) to achieve endotoxin removal while preserving molecular weight. This parameter optimization resolves the contradiction between endotoxin reduction and molecular weight maintenance.
Solution Approach 2:
The patent introduces a basic solution as an intermediary medium that facilitates endotoxin removal without directly degrading the chitosan polymer. The basic solution acts as a mediator that selectively interacts with endotoxins while leaving the chitosan structure intact, thus resolving the contradiction between effective endotoxin removal and molecular weight preservation.
2Object-affected harmful factors
If harsh chemical treatments are used to remove endotoxins, then endotoxin levels are reduced, but production cost increases and molecular weight is degraded
Solution Approach 1:
The patent uses inexpensive, readily available basic solutions (such as sodium hydroxide or ammonia solutions) that can be easily prepared and disposed of after use. This approach replaces expensive specialized reagents with cheap, common chemicals, significantly reducing production costs while maintaining effective endotoxin removal.
Solution Approach 2:
The patent optimizes treatment parameters (pH 10-12, temperature 60-100°C, time 30-120 minutes) to achieve effective endotoxin removal under mild conditions, eliminating the need for harsh chemical treatments and expensive specialized equipment, thereby reducing overall production costs.
3Object-affected harmful factors
If extensive purification steps are used to achieve medical grade purity, then endotoxin levels are reduced, but production complexity and cost increase
Solution Approach 1:
The patent performs endotoxin removal as a preliminary step early in the chitosan production process, before the chitosan is formulated into final medical products. This preliminary treatment simplifies the overall process by addressing endotoxin contamination at the source, eliminating the need for complex downstream purification steps.
Solution Approach 2:
The patent uses a simple basic solution as an intermediary treatment medium that can be easily applied and removed, simplifying the purification process. This intermediary approach replaces complex multi-step purification protocols with a single, straightforward treatment step, reducing process complexity while achieving medical-grade purity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves ultra-low endotoxin levels (near 0 EU/gm) in chitosan, maintaining high molecular weight and ensuring the chitosan's suitability for medical-grade applications, including tissue scaffolding and drug delivery systems, while being cost-effective and scalable.
Implementation Method 1
adding ammonia to the reaction mixture to raise pH of the reaction mixture to above 9.5
Implementation Method 2
heating the reactive mixture with a pH above 9.5 at temperatures of at least 130 C for at least 20 minutes
Implementation Method 3
sparging the cooled reaction mixture with an inert gas to remove ammonia
Implementation Method 4
drying the fiber mass at a temperature below 100° C.
Data Source
AI summary
A process of making low-endotoxin chitosan or alkali-stable polysaccharide is performed by suspending bulk chitosan fibers or flakes or alkali-stable polysaccharide to form a reaction mixture in an aqueous solution of alcohol. Ammonia is the added to the reaction mixture to raise pH of the reaction mixture to above 9.5. The reactive mixture with a pH above 9.5 is heated at a temperature of at least 130° C. for at least 20 minutes. The heated reaction mixture is cooled to less than 60° C. and then sparged with an inert gas to remove ammonia. Separating the chitosan or alkali-stable polysaccharide from the sparged reaction mixture. The chitosan fibers or polysaccharide is rinsed with an endotoxin-free aqueous liquid to form a rinsed fiber mass. The rinsed fiber mass is further rinsed with an alcohol to remove water, and dried at a temperature below 100° C. to form the low-endotoxin chitosan or alkali-stable polysaccharide.